All News about Clene Inc
MS Drug Could Counter Poor Working Memory
November 26, 2024
European Commission Imposes Hefty Fine on Firm for Blocking Rival MS Drug Developer
November 07, 2024
Topics
Intellectual Property
Exposures
Intellectual Property
Disruptions in Purine Metabolism Cited in Parkinson’s Development
October 02, 2024
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
September 16, 2024
Exposures
Product Safety
Does Multiple Sclerosis Reduce Risk of Developing Dementia?
September 11, 2024
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 06, 2024
Via Benzinga
UCSF Team Tests New Drug That Could Reverse Multiple Sclerosis
August 19, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|